Navigation Links
Vacuum device increase breasts

Scientists from Georgia have found that, although a vacuum device promoted as a breast-enhancer does increase a woman's cup size, few women may have the time and commitment to use the product. The device, known as the BRAVA system, requires women to wear two plastic domes over their breasts for 10 hours a day for 10 weeks straight.// The domes are connected to a battery operated, computerized vacuum device. Skipping even a day adds a week to the treatment.

However, the device does seem to be a viable alternative to surgery for women who want bigger breasts, according to Dr. Richard J. Greco, of the Georgia Institute for Plastic Surgery in Savannah. It is only appropriate for women who are a B cup or smaller and are willing to commit to the price and time required, he said.

Previous studies conducted by the inventors of BRAVA suggested that the device could lead to tissue growth not just temporary swelling resulting in long-term breast enhancement. Greco, a member of the American Society of Plastic Surgeons' Device and Technology Committee, attempted to verify those results in an independent study.

While many women expressed interest in the device, only eight women ended up in the study.Some women couldn't commit to the time involved, others had breasts that were too large or chests that were too narrow. Some felt the system was not worth the relatively small gain (one cup size) made in breast size.

According to Greco, a few patients dropped out because we could not make a definite statement as to whether or not this tissue growth stimulation would increase their likelihood of breast cancer in the future. The report says, of the original eight, two dropped out "because of the inconvenience the device created in their lives. Three of the six women who completed the study experienced an increase in breast size that was equal to one bra cup or more. The remaining three women experienced roughly half as much breast tissue growth, study findings indicate.

The "amount of enhancement is relative to (the woman's) size," Greco said. However, the increased breast size remains evident up to 15 months later, according to previous reports. Greco's study did not include long-term follow-up data.

The device is "relatively inconvenient, is heavy, and induces a fair amount of skin irritation along the silicone border/skin interface," Greco writes. "Yet the motivation to have larger breasts seems to overcome this in the correctly chosen individual." The system is also known to cause initial swelling that goes down as the treatment continues, Greco said.

And many of the women experienced technical difficulties with malfunctioning equipment and needed 15 to 30 minutes on a biweekly basis with customer service to help them through the process. The system can be worn during sleep but an alarm will sound if the user inadvertently rolls over the cord, Greco said. This can result in sleep deprivation, a reason one woman cited when she dropped out of the study. The other woman dropped out because of the time commitment required, the researcher said.

Although reviewed by the US Food and Drug Administration (FDA), BRAVA is not regulated by the agency. The ideal candidate for BRAVA would be an individual who does not have a full time job, or someone who begins to use the device immediately after work and is able to sleep in it, Greco said.

Those who obtain the roughly $2,000 device from an authorized physician and are not satisfied with the results or with the inconvenience, however, will not be able to obtain a refund, according to the researcher. "Understand that you're trading off the risks of surgery with the inconvenience of having to wear" the BRAVA device, Greco said.


'"/>




Related medicine news :

1. DVT Treatment Vacuums Away Blood Clots – Prevents Disabilit
2. Alerts for safety of heart device
3. FDA approves new device to treat womens bleeding disorder
4. A new hearing device improves hearing
5. New device for detecting artery blockages
6. New device for discerning Osteoarthritis
7. Screening device for ovarian cancer
8. Innovative device aids in advanced heart failure
9. Latest device for identifying Melanomas
10. Useful device makes spinal surgery safer
11. New device aids esophagal cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: